A 14-week, Randomized, Double-Blinded, Placebo-Controlled Monotherapy Trial of Pregabalin in Patients With Fibromyalgia

This publication has 26 references indexed in Scilit:

• The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12
  International Journal Of Clinical Practice, 2007
• Ca2+ channel α2δ ligands: novel modulators of neurotransmission
  Trends in Pharmacological Sciences, 2007
• Missing Data Imputation in Two Phase III Trials Treating HIV1 Infection
  Journal of Biopharmaceutical Statistics, 2007
• Identification of the α₂-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin
  Proceedings of the National Academy of Sciences, 2006
• Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double‐blind, placebo‐controlled trial
  Arthritis & Rheumatism, 2005
• Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia
  Arthritis & Rheumatism, 2002
• Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
  PAIN®, 2001
• The prevalence and characteristics of fibromyalgia in the general population
  Arthritis & Rheumatism, 1995
• The american college of rheumatology 1990 criteria for the classification of fibromyalgia
  Arthritis & Rheumatism, 1990
• The Hospital Anxiety and Depression Scale
  Acta Psychiatrica Scandinavica, 1983